%0 Book %A National Academies of Sciences, Engineering, and Medicine %E Bain, Lisa %E Norris, Sheena M. Posey %E Stroud, Clare %T Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop %@ 978-0-309-69096-6 %D 2022 %U https://nap.nationalacademies.org/catalog/26635/methadone-treatment-for-opioid-use-disorder-improving-access-through-regulatory %> https://nap.nationalacademies.org/catalog/26635/methadone-treatment-for-opioid-use-disorder-improving-access-through-regulatory %I The National Academies Press %C Washington, DC %G English %K Health and Medicine %P 180 %X Methadone is a Food and Drug Administration- (FDA-) approved medication for treating opioid use disorder (OUD), a chronic brain disease that affects more than 2.7 million people in the United States aged 12 and older. Despite its effectiveness in saving lives, many barriers impede access to, initiation of, and retention in methadone treatment for OUD. To address these barriers, on March 3 and 4, 2022, the National Academies of Sciences, Engineering, and Medicine hosted a workshop on "Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws," at the request of the Office of National Drug Control Policy in the Executive Office of the President. This publication summarizes the presentation and discussion of the workshop. %0 Book %A Institute of Medicine %T Living Well with Chronic Illness: A Call for Public Health Action %@ 978-0-309-22127-6 %D 2012 %U https://nap.nationalacademies.org/catalog/13272/living-well-with-chronic-illness-a-call-for-public-health %> https://nap.nationalacademies.org/catalog/13272/living-well-with-chronic-illness-a-call-for-public-health %I The National Academies Press %C Washington, DC %G English %K Health and Medicine %P 350 %X In the United States, chronic diseases currently account for 70 percent of all deaths, and close to 48 million Americans report a disability related to a chronic condition. Today, about one in four Americans have multiple diseases and the prevalence and burden of chronic disease in the elderly and racial/ethnic minorities are notably disproportionate. Chronic disease has now emerged as a major public health problem and it threatens not only population health, but our social and economic welfare. Living Well with Chronic Disease identifies the population-based public health actions that can help reduce disability and improve functioning and quality of life among individuals who are at risk of developing a chronic disease and those with one or more diseases. The book recommends that all major federally funded programmatic and research initiatives in health include an evaluation on health-related quality of life and functional status. Also, the book recommends increasing support for implementation research on how to disseminate effective longterm lifestyle interventions in community-based settings that improve living well with chronic disease. Living Well with Chronic Disease uses three frameworks and considers diseases such as heart disease and stroke, diabetes, depression, and respiratory problems. The book's recommendations will inform policy makers concerned with health reform in public- and private-sectors and also managers of communitybased and public-health intervention programs, private and public research funders, and patients living with one or more chronic conditions. %0 Book %A National Academies of Sciences, Engineering, and Medicine %E Bonnie, Richard J. %E Ford, Morgan A. %E Phillips, Jonathan K. %T Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use %@ 978-0-309-45954-9 %D 2017 %U https://nap.nationalacademies.org/catalog/24781/pain-management-and-the-opioid-epidemic-balancing-societal-and-individual %> https://nap.nationalacademies.org/catalog/24781/pain-management-and-the-opioid-epidemic-balancing-societal-and-individual %I The National Academies Press %C Washington, DC %G English %K Health and Medicine %P 482 %X Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring. %0 Book %A Institute of Medicine %E O'Brien, Charles P. %E Oster, Maryjo %E Morden, Emily %T Substance Use Disorders in the U.S. Armed Forces %@ 978-0-309-26055-8 %D 2013 %U https://nap.nationalacademies.org/catalog/13441/substance-use-disorders-in-the-us-armed-forces %> https://nap.nationalacademies.org/catalog/13441/substance-use-disorders-in-the-us-armed-forces %I The National Academies Press %C Washington, DC %G English %K Health and Medicine %K Conflict and Security Issues %P 416 %X Problems stemming from the misuse and abuse of alcohol and other drugs are by no means a new phenomenon, although the face of the issues has changed in recent years. National trends indicate substantial increases in the abuse of prescription medications. These increases are particularly prominent within the military, a population that also continues to experience long-standing issues with alcohol abuse. The problem of substance abuse within the military has come under new scrutiny in the context of the two concurrent wars in which the United States has been engaged during the past decadeā€”in Afghanistan (Operation Enduring Freedom) and Iraq (Operation Iraqi Freedom and Operation New Dawn). Increasing rates of alcohol and other drug misuse adversely affect military readiness, family readiness, and safety, thereby posing a significant public health problem for the Department of Defense (DoD). To better understand this problem, DoD requested that the Institute of Medicine (IOM) assess the adequacy of current protocols in place across DoD and the different branches of the military pertaining to the prevention, screening, diagnosis, and treatment of substance use disorders (SUDs). Substance Use Disorders in the U.S. Armed Forces reviews the IOM's task of assessing access to SUD care for service members, members of the National Guard and Reserves, and military dependents, as well as the education and credentialing of SUD care providers, and offers specific recommendations to DoD on where and how improvements in these areas could be made.